These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8196938)

  • 21. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
    Sitohy M; Billaudel S; Haertlé T; Chobert JM
    J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine.
    Oh KW; Lee CK; Kim YS; Eo SK; Han SS
    J Ethnopharmacol; 2000 Sep; 72(1-2):221-7. PubMed ID: 10967475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an aciclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice.
    Johnson TP; Frey R; Modugno M; Brennan TP; Margulies BJ
    Int J Antimicrob Agents; 2007 Nov; 30(5):428-35. PubMed ID: 17851051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
    Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
    Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.
    Pulliam L; Panitch HS; Baringer JR; Dix RD
    Antimicrob Agents Chemother; 1986 Dec; 30(6):840-6. PubMed ID: 3028250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
    Kurokawa M; Hozumi T; Tsurita M; Kadota S; Namba T; Shiraki K
    J Pharmacol Exp Ther; 2001 Apr; 297(1):372-9. PubMed ID: 11259565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
    Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
    Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
    [No Abstract]   [Full Text] [Related]  

  • 34. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice.
    Kuo YC; Lee YC; Leu YL; Tsai WJ; Chang SC
    Antiviral Res; 2008 Nov; 80(2):206-12. PubMed ID: 18621082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
    Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
    Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
    Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
    Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.